Carvedilol differentially regulates cytokine production from activated human peripheral blood mononuclear cells

Cardiovascular Drugs and Therapy

Volumn 18, Issue 3, 2004, Pages 183-188

  Yang, Shih Ping ^a   Ho, Ling Jun ^b   Cheng, Shu Meng ^a   Hsu, Yu Lin ^a   Tsao, Tien Ping ^a   Chang, Deh Ming ^a   Lai, Jenn Haung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

carvedilol; cytokine; macrophage; monocyte

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 12; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CARBAZOLES; CELLS, CULTURED; CHINA; CONCANAVALIN A; FORECASTING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; PHYTOHEMAGGLUTININS; PROPANOLAMINES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASODILATOR AGENTS;

EID: 3142729922     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000033638.37830.f7     Document Type: Article

References (32)

1. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-1890.
2. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
3. Meuwissen M, Piek JJ, van der Wal AC, et al. Recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation. J Am Coll Cardiol 2001;37:1271-1276.
4. Piek JJ, van der Wal AC, Meuwissen M, et al. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000;35:963-967.
5. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, Teitelbaum SL. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 1985;76:219-224.
6. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 1998;58:249-261.
7. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-469.
8. Serrano CV, Ramires JAF, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-1283.
9. Serruys PW, Foley DP, Hofling B, et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: Final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits. Circulation 2000;101:1512-1518.
10. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001;344:1358-1365.
11. Lai JH, Ho LJ, Lu KC, Chang DM, Shaio MF, Han SH. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J Immunol 2001;166:6914-6924.
12. Capsoni F, Minonzio F, Ongari AM, Rizzardi GP, Lazzarin A, Zanussi C. Monocyte-derived macrophage function in HIV-infected subjects: In vitro modulation by rIFN-gamma and rGM-CSF. Clin Immunol Immunopathol 1992;62:176-182.
13. Akewanlop C, Watanabe M, Singh B, Walker M, Kufe DW, Hayes DF. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody. Cancer Res 2001;61:4061-4065.
14. Ho LJ, Chang DM, Shiau HY, et al. Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells. Scand J Rheumatol 2001;30:346-352.
15. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-1318.
16. Jude B, Agraou B, McFadden EP, et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994;90:1662-1668.
17. Lee WH, Lee Y, Kim JR, et al. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients. Exp Mol Med 1999;31:159-164.
18. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-798.
19. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169-175.
20. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994;90:694-699.
21. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999;100:2135-2139.
22. Saitoh T, Kishida H, Tsukada Y, et al. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol 2000;35:655-665.
23. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999;19:734-742.
24. Varadhachary AS, Monestier M, Salgame P. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol 2001;213:45-51.
25. Zhao L, Cuff CA, Moss E, et al. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 2002;277:35350-35356.
26. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003;163:1117-1125.
27. Uyemura K, Demer LL, Castle SC, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atheroslcerosis. J Clin Invest 1996;97:2130-2138.
28. Cheng SM, Yang SP, Ho LJ, Tsao TP, Chang DM, Lai JH. Carvedilol modulates in-vitro granulocyte-macrophage colony-stimulating factor-induced interleukin-10 production in U937 cells and human monocytes. Immunol Invest 2003;32:43-56.
29. Mazzone A, De Servi S, Mazzucchelli I, et al. Increased concentrations of inflammatory mediators in unstable angina: Correlation with serum troponin T. Heart 2001;85:571-575.
30. Liuzzo G, Vallejo AN, Kopecky SL, et al. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation 2001;103:1509-1514.
31. Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003;108:1232-1237.
32. Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-γ and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol 2003;41:340-345.